Market revenue in 2024 | USD 98.2 million |
Market revenue in 2030 | USD 208.8 million |
Growth rate | 13.4% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.39% in 2024. Horizon Databook has segmented the Canada pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The pancreatic cancer treatment market in Canada is poised for growth, driven by the rising incidence of the disease and advancements in treatment modalities. According to the World Health Organization (WHO).
Despite the relatively lower incidence compared to other cancers, the disease's high fatality rate and late-stage diagnosis, with over 60% of cases diagnosed at advanced stages, continue to challenge the healthcare system.
The market is dominated by chemotherapy regimens. In addition, surgical resection remains the preferred option for early-stage tumors, complemented by adjuvant chemotherapy to improve survival outcomes.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Canada pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account